| Fund ID | 805-3998686672 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | Yes |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 8% |
| Fund | Type | Gross assets |
|---|---|---|
| Highvista (offshore) Ltd. | Hedge | $669.5M |
| Highvista I Limited Partnership | Hedge | $634.2M |
| Highvista 1.5 (offshore) Ltd | Hedge | $630.4M |
Highvista Biotechnology Specialist Fund Ltd reports $238.1 million in gross assets, among the top 28% of private funds by size.
The stated minimum investment is $5 million.
Highvista Biotechnology Specialist Fund Ltd is managed by Highvista Strategies LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.